Table 4 Correlation between clinicopathological features and morbidity and mortality in the first 30 days following radical cystectomy

Age (years)

 Mean ± SD

59.6 ± 9.3

58.4 ± 8.3

0.795

Gender

 Female

7

70

3

30

0.95

 Male

44

71

18

29

Residency

 Urban

33

73.3

12

26.7

0.55

 Rural

18

66.7

9

33.3

Comorbidity

 No

34

70.8

14

29.2

1

 Yes

17

70.8

7

29.2

Smoking

 Non-smoker

14

66.7

7

33.3

0.68

 Smoker

37

72.5

14

27.5

Hydronephrosis

 Yes

21

76.9

12

23.1

0.22

 No

30

63.6

9

26.4

Hydronephrosis Laterality

 Unilateral

11

57.9

8

42.1

0.33

 Bilateral

10

71.4

4

28.6

Hydronephrosis Severity

 Mild

7

53.8

6

46.2

0.28

 Moderate to marked

14

70

6

30

Clinical T

 T2

20

74.1

7

25.9

0.01

 T3b

30

78.9

8

21.1

 T4

10

16.7

5

83.3

Clinical N

 N0

43

71.7

17

28.3

0.73

 N1,N2

8

66.7

4

33.3

Clinical stage

 II

17

37.9

6

26.1

0.82

 IIIA

29

72.5

11

27.5

 IIIB

5

62.5

3

37.5

Risk group

 Low risk

11

73.3

4

16.7

0.81

 High risk

40

70.2

17

19.8

Grade

 II

24

70.6

10

29.4

0.97

 III

27

71.1

11

28.9

Clinical response

 CR/ PR

35

74.5

12

15.5

0.15

 SD

5

45.5

6

55.5

 PD

11

78.6

3

11.4

Downstaging

 Yes

16

69.6

7

30.4

0.87

 No

35

71.4

14

28.6

Associated bilharziasis

 Yes

17

65.4

9

34.6

0.44

 No

34

73.9

9

23.1

Pathological complete response (pCR)

 Yes

8

72.7

3

27.3

0.89

 No

43

70.5

18

29.5

Type of urinary diversion

 Ileal conduit

39

73.6

14

26.4

*

 Orthotopic neobladder

9

69.2

4

30.8

 Rectal bladder

1

50

1

50

 Cutaneous ureterostomy

2

50

2

50